Please ensure Javascript is enabled for purposes of website accessibility Circular(No.96)- Drug Safety Update Dupilumab & Risk of Ocular Adverse Reactions. Circular(No.96)- Drug Safety Update Dupilumab & Risk of Ocular Adverse Reactions.
Alert :

Welcome to the beta version of the eHealth portal; our goal is to improve your experience by providing better eServices

Circular(No.96)- Drug Safety Update Dupilumab & Risk of Ocular Adverse Reactions.

Content Details
General Circular
Circular(No.96)- Drug Safety Update Dupilumab & Risk of Ocular Adverse Reactions.
01/01/2023

Drug Safety Update Dupilumab & Risk of Ocular Adverse Reactions.

View Download
21
Circular(No.96)- Drug Safety Update Dupilumab & Risk of Ocular Adverse Reactions.
Was this page helpful?
0 visitors liked this page of total 0 visitors
Be the first to evaluate this page

Add Reason (choose at least one)

الرجاء اختيار سببان كحد أعلى

هذا الحقل مطلوب

الرجاء كتابة نص صحيح

الملاحظات يجب ان تكون اقل من ٢٥٠ حرف

Share this page
Follow Us On